For research use only
| Cat No. | ABC-TC0466 |
| Product Type | Mouse Breast Cancer Cell Lines |
| Cell Type | Epithelial |
| Species | Mouse |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Breast |
| Disease | AdenoCarcinoma |
| Product Code | JC cell, JC cell line |
Tumorigenecity: Isoenzyme: Histopathology: adenocarcinomaSubculture: Split ratio: Media change: Reverse transcritase: Production
JC is a mouse mammary adenocarcinoma tumor cell line originally isolated from a spontaneous primary mammary adenocarcinoma of a 1-year-6-month-old female BALB/cRos mouse. It exhibits an epithelial-like morphology and grows as adherent monolayers in vitro, with a reported doubling time of approximately 12-16 hours under standard culture conditions. Cytogenetic analysis shows a hypo-tetraploid karyotype (26-100 chromosomes). This cell line was developed to model spontaneous mammary carcinoma in syngeneic hosts and has been used in murine breast cancer research, including tumorigenicity studies in immunocompetent mice. JC cell line supports investigations into signaling pathways driving breast cancer proliferation, oncogenic transformation, and therapeutic response mechanisms. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | JC cell, JC cell line |
| Species | Mouse |
| Cat.No | ABC-TC0466 |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Epithelial |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Breast |
| Disease | AdenoCarcinoma |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Mouse Breast Cancer Cell Lines |
JC cells are used as an in vitro and in vivo model of mouse mammary adenocarcinoma to investigate tumor cell proliferation, signaling pathways involved in breast cancer progression, and therapeutic response screening. They are particularly useful in syngeneic tumor models for immune oncology studies and preclinical evaluation of anticancer agents relevant to mammary gland tumors.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
